AzTrials
AzTrials

Accumbo Frontal TractACCUMBENSNCT03496285

Accumbofrontal Tract Study in 2 Populations of Patients With Anorexia Nervosa and Obsessional Compulsive Disorder and Healthy Volunteer

A study testing Multimodal MRI with diffusion sequence for anorexia nervosa patient, Multimodal MRI with diffusion sequence for obsessional compulsive disorder patient and Multimodal MRI with diffusion sequence for healthy volunteer in people with Accumbo Frontal Tract, run by Poitiers University Hospital at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Restrictive anorexia nervosa and TOCs are psychiatric diseases which shares a common pathophysiological substrate We hypothesize that anorexia patients and patients with OCD have structural and functional changes in the accumbofrontal tract. Read more about this study

Who is it for?
Ages 18 to 65 years, women onlyHealthy volunteers can take part
Conditions the study is for
Accumbo Frontal Tract
What is being tested?
Multimodal MRI with diffusion sequence for anorexia nervosa patient, Multimodal MRI with diffusion sequence for obsessional compulsive disorder patient and Multimodal MRI with diffusion sequence for healthy volunteer
Type of treatment
Surgery or procedure
How many people
30 participants
Where
1 siteFrance
Study dates
9 May 2018to 24 Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Female patients
  • Age between 18 and 65 years
  • Subjects free to give their written consent
  • For anorexia nervosa :
  • Patients meeting the diagnostic criteria for anorexia nervosa according to DSM5 (American Psychiatric Association): low weight (<85% of expected weight for age and height), fear of gaining weight or becoming fat, distortion of body image, and amenorrhea for more than 3 months
  • Treatment with at least one antidepressant and one anxiolytic
Show all 13Show fewer
  • For OCD :
  • Patients meeting the diagnostic criteria of OCDs according to DSM5 (American Psychiatric Association) : presence of obsessions and / or compulsions, resulting in clinically significant suffering (loss of at least one hour per day) or impairment at the social, occupational level or in another important area of life. These symptoms are not due to the physiological effects of a substance or a general medical condition and cannot be better explained by the symptoms of another psychiatric disorder.
  • Patients with homogeneous OCD in obsession and compulsion.
  • Normal weight compared to expected weight for age and height
  • Treatment with at least one antidepressant and one anxiolytic
  • ForHealthy volunteer
  • •Normal weight compared to expected weight for age and height

Who cannot join

  • Male
  • Age <18 years or> 65 years
  • Pregnancy
  • Absence of free and informed consent signature
  • Current processing by rTMS
  • Somatic intercurrent pathologies: neurological, cardiological, pneumological, renal, hepatic, endocrine, metabolic disorders ...
Show all 10Show fewer
  • Mental retardation (WAIS-IV QI <70)
  • Primary Amenorrhea
  • Absolute contraindication or relative to the realization of a magnetic resonance imaging without injection of contrast medium
  • Old or intercurrent psychotic pathology

Trial locations and contacts

1 site in 1 country.

France1 site
  • CH Laborit

    Poitiers, 86021

Other trials in France

About this study

Official title: Multimodal MRI Study of Accumbofrontal Tract in Anorexia Nervosa and Obessional Compulsive Disorder : Search for Structural and Functional Changes Between Orbito-frontal Cortex and Accumbens Nucleus Subdivisions

Restrictive anorexia nervosa and TOCs are psychiatric diseases which shares a common pathophysiological substrate We hypothesize that anorexia patients and patients with OCD have structural and functional changes in the accumbofrontal tract. The main objective of this study will be to compare the structure and the connectivity of this tract in MRI with diffusion sequences (DTI tractography) and resting-state, in 3 distinct populations of anorexic patients, patients with OCD and healthy patients. The role of the accumbo-frontal tract in the cortico-striato-hypothalamo-cortical circuit seems to be established. DTI tractography will allow the measurement of functional anisotropy (FA), a parameter that evaluates the diffusion of water molecules along the white matter fibers, and therefore the potential alteration of the studied tract. Resting state sequences will allow to estimate the BOLD signal and the functionality of the tract.

Being tested
Multimodal MRI with diffusion sequence for anorexia nervosa patient, Multimodal MRI with diffusion sequence for obsessional compulsive disorder patient, Multimodal MRI with diffusion sequence for healthy volunteer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multimodal MRI with diffusion sequence for anorexia nervosa patientRadiation

    Multimodal MRI with diffusion sequence, resting state, T2, T1 without gadolinium contrast

  • Multimodal MRI with diffusion sequence for obsessional compulsive disorder patientRadiation

    Multimodal MRI with diffusion sequence, resting state, T2, T1 without gadolinium contrast

  • Multimodal MRI with diffusion sequence for healthy volunteerRadiation

    Multimodal MRI with diffusion sequence, resting state, T2, T1 without gadolinium contrast

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fractional Anisotropy (probabilistic tractography)

    Evaluate the mean functional anisotropy value for fiber bundles connecting the orbito-frontal cortex and the nucleus accumbens

    Measured: 20 minutes

Secondary outcomes (1)
  1. BOLD Signal (resting state)

    Evaluate the value of the BOLD-signal of the fiber bundles connecting the orbito-frontal cortex and the nucleus accumbens

    Measured: 20 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Apr 2018
  2. Study start9 May 2018
  3. Primary completion24 Nov 2021
  4. Study completion24 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03496285
Sponsor's protocol ID
ACCUMBENS
Acronym
ACCUMBENS
Status last verified
Mar 2022
First submitted
5 Apr 2018
Last updated
31 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Multimodal MRI with diffusion sequence for anorexia nervosa patient, Multimodal MRI with diffusion sequence for obsessional compulsive disorder patient and Multimodal MRI with diffusion sequence for healthy volunteer in people with Accumbo Frontal Tract, run by Poitiers University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fractional Anisotropy (probabilistic tractography) (time frame: 20 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in